Schreiber Taylor 4

What Happened

• Taylor Schreiber, CEO of Shattuck Labs (STTK), acquired 25,610 shares on May 12, 2026 at $1.08 per share for a reported total of $27,777 (transaction code A — grant/award or other acquisition). On the same date the reporting person also recorded an exercise/conversion of a derivative (transaction code M) covering 25,610 shares (derivative disposition).
• In plain terms: Schreiber received 25,610 common shares and a related derivative (warrant) position was exercised/converted the same day. This is an acquisition by an insider (generally viewed as a bullish signal relative to a sale), not a sale.

Key Details

• Transaction date: May 12, 2026; Form filed May 13, 2026 (timely).
• Share acquisition: 25,610 shares @ $1.08 = $27,777.
• Derivative action: 25,610 shares listed as an exercise/conversion of a derivative (no separate exercise price shown on the provided excerpt).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes of note:
  • F1: These shares and accompanying warrants were originally issued in a private placement that closed Aug 25, 2025; combined price per share and accompanying warrant in that placement was $0.8677.
  • F2: The warrants are exercisable after public announcement of certain Phase 1 clinical trial data and planned Phase 2 design. The filing's exercise entry indicates a conversion/exercise event occurred on May 12, 2026.

Context

• The filing shows an acquisition plus the exercise/conversion of a derivative (warrant). For retail investors: an insider acquiring shares is typically more informative than routine sales, but filings alone do not reveal the insider's motive.
• No indication in the provided excerpt that shares were immediately sold (no cashless/market sale reported).